APA

Jiang Z., Liu X., Yuan Z., He H., Wang J., Zhang X., Gong Z., Hou L., Shen L., Guo F., Zhang J., Wang J., Xu D., Liu Z., Li H., Chen X., Long C., Li J. & Chen S. (2019). Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis. : ACS medicinal chemistry letters.

Chicago

Jiang Zhigan, Liu Xing, Yuan Zhiliang, He Haiying, Wang Jing, Zhang Xiao, Gong Zhen, Hou Lijuan, Shen Liang, Guo Fengxun, Zhang Jiliang, Wang Jianhua, Xu Deming, Liu Zhuowei, Li Haijun, Chen Xiaoxin, Long Chaofeng, Li Jian and Chen Shuhui. 2019. Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis. : ACS medicinal chemistry letters.

Harvard

Jiang Z., Liu X., Yuan Z., He H., Wang J., Zhang X., Gong Z., Hou L., Shen L., Guo F., Zhang J., Wang J., Xu D., Liu Z., Li H., Chen X., Long C., Li J. and Chen S. (2019). Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis. : ACS medicinal chemistry letters.

MLA

Jiang Zhigan, Liu Xing, Yuan Zhiliang, He Haiying, Wang Jing, Zhang Xiao, Gong Zhen, Hou Lijuan, Shen Liang, Guo Fengxun, Zhang Jiliang, Wang Jianhua, Xu Deming, Liu Zhuowei, Li Haijun, Chen Xiaoxin, Long Chaofeng, Li Jian and Chen Shuhui. Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis. : ACS medicinal chemistry letters. 2019.